Related Experiment Video
Updated: Aug 4, 2025

09:45
Harvesting Venom Toxins from Assassin Bugs and Other Heteropteran Insects
Published on: April 21, 2018
13.2K
[Hymenoptera venom allergy: what's new in 2023]
Mhedi Belkoniene1, Maxime Ringwald1, Annette Leimgruber1
1Service d'immunologie et allergie, Département de médecine, Centre hospitalier universitaire vaudois, 1011 Lausanne.
Revue Medicale Suisse
|April 5, 2023
Summary
Hymenoptera venom allergy diagnosis and treatment are evolving due to product limitations. This review covers updated diagnostic tools, mastocytosis screening, and immunotherapy protocols for venom desensitization.
Area of Science:
- Allergology and Immunology
- Clinical Medicine
Background:
- Hymenoptera venom allergy presents significant challenges in allergology.
- Recent shortages of specific venom products necessitate revised diagnostic and therapeutic strategies in Switzerland.
Approach:
- This review synthesizes current diagnostic methodologies, including recombinant serologies.
- It examines updated recommendations for screening indolent systemic mastocytosis.
- Various immunotherapy protocols for venom desensitization are discussed.
Key Points:
- Recombinant serologies offer advanced diagnostic capabilities for Hymenoptera venom allergy.
- Screening for indolent systemic mastocytosis requires updated guidelines.
- Immunotherapy protocols involve both aqueous and aluminum hydroxide-adsorbed purified venoms.
Conclusions:
- Adapting diagnostic and therapeutic approaches is crucial for managing Hymenoptera venom allergy effectively.
- The review provides a comprehensive overview of current practices and future directions in venom allergy management.
Related Concept Videos
Allergic Reactions
28.0K
Overview
28.0K
Cross-reactivity
31.4K
Overview
31.4K
Allergic Drug Reactions
905
Allergic reactions related to drugs are hypersensitivity responses driven by the immune system and bear no connection to the drug's therapeutic action. While drugs in isolation do not trigger an immune response, they can interact with endogenous proteins to form antigens. These antigens stimulate lymphocytes to produce antibodies. IgE-type antibodies attach themselves to mast cells. Upon subsequent exposure to the same stimulus, the antigen-antibody interaction is initiated, unleashing...
905
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
368
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
368

